Gynecology For The Everyday Woman

Definition 

Chronic pelvic pain is pain in the lower abdomen or pelvis that lasts ≥6 months, and is severe enough to affect daily life. It’s a symptom (not a single disease) and can come from gynaecological, urological, gastrointestinal, musculoskeletal or nervous-system causes — often more than one.  

How common is it? (quick regional comparison)

Prevalence estimates vary widely because studies use different definitions and populations. Typical ranges from major reviews:

• Worldwide / general figures: ~4%–27% of women (most systematic reviews give a broad range).  

• United Kingdom: community / primary-care studies report about 14–24% in some samples; CPP is as common in primary care as migraine or back pain. UK guidance highlights long diagnostic delays.  

• United States: commonly quoted ≈1 in 7 women (≈14%) in population studies; other surveys give point estimates up to ~15–20% depending on age group.  

• Europe / Asia / Africa: country and study-specific estimates vary (many studies report single-digit to mid-20% ranges). Data quality and under-reporting make exact comparisons difficult.  

Bottom line: CPP is common and under-recognised; expect considerable variation between studies and settings.  

CAUSES:

Gynaecological Causes

• Endometriosis (most common identifiable cause; NICE, RCOG)
• Adenomyosis (RCOG)
• Chronic pelvic inflammatory disease (PID) or sequelae (e.g., adhesions; NICE, RCOG)
• Pelvic congestion syndrome (varicose veins in pelvis; TOG, NICE)
• Ovarian cysts or remnants
• Uterine fibroids
• Primary dysmenorrhoea (no underlying pathology; NICE)

Urological Causes

• Interstitial cystitis/bladder pain syndrome (RCOG)
• Recurrent urinary tract infections

Gastrointestinal Causes

• Irritable bowel syndrome (RCOG)
• Inflammatory bowel disease (e.g., Crohn’s, ulcerative colitis)

Musculoskeletal Causes

• Pelvic floor myalgia or dysfunction (RCOG)
• Nerve entrapment (e.g., pudendal neuralgia; NICE)
• Myofascial pain

Psychological/Social Factors

• Often contribute alongside physical causes (e.g., depression, stress; RCOG)
• Central sensitization (neuropathic pain; NICE)

Other Causes

• Postsurgical pain (e.g., after caesarean or hysterectomy; NICE)
• Adhesions (post-surgical or inflammatory; RCOG)
• Malignancy (rare, but consider if red flags present)

Long-term consequences

• Chronic pain and disability: ongoing pelvic pain that limits work, social life and exercise.

• Mental health impact: higher rates of anxiety, depression and reduced quality of life.

• Sexual and relationship difficulties: pain with intercourse, reduced intimacy.

• Co-morbid conditions: overlaps with endometriosis, bladder pain syndrome, IBS, pelvic floor muscle dysfunction and neuropathic pain syndromes.

• Health-system cost & delays: many people wait years for diagnosis and multidisciplinary care.  

Typical symptoms (what people notice)

• Deep ache or sharp pain in lower abdomen/pelvis lasting months.

• Pain during sex (dyspareunia), bowel movements, or urination.

• Variable timing — persistent, fluctuating with cycle, or intermittent flares.

• Fatigue, sleep disturbance and mood changes are common.  

Investigations (practical approach)

1. Thorough history & pelvic exam (ask about menstrual, urinary, bowel, psychosocial and sexual symptoms).

2. Basic tests: urine dipstick/culture, pregnancy test, STI screening if indicated, bloods (as guided).

3. Imaging where indicated: pelvic ultrasound (TVUS) and sometimes MRI to look for endometriosis, fibroids or other pathology.

4. Assess other systems: bowel evaluation (e.g., colonoscopy / CT if red flags), urology review for bladder pain, and pelvic-floor assessment/physiotherapy.

5. Special tests reserved for select cases: diagnostic laparoscopy (if surgical treatment planned or diagnosis uncertain), urodynamics for bladder symptoms, nerve testing when neuropathic pain suspected.

6. Use a biopsychosocial assessment — screen for mood, sleep, pain behaviour and social factors.  

Treatment options (stepped, multidisciplinary)

Principle: treat identifiable causes, manage pain, restore function, and address mental health — combine approaches.

Self-help & supportive care

• Education, pain coping strategies, sleep hygiene, gradual activity and return-to-work plans.

• Pelvic-floor physiotherapy for muscle dysfunction.  

Medical

• Analgesia: WHO-style approach (NSAIDs, careful use of opioids only when necessary and supervised).

• Hormonal treatments (combined hormones, progestogens, GnRH agonists) for suspected endometriosis-related pain.

• Neuropathic agents (e.g., amitriptyline, nortriptyline, gabapentin/pregabalin) when neuropathic pain features.

• Treat co-morbid conditions: IBS, bladder pain syndrome, infections.  

Procedural / surgical

• Diagnostic and therapeutic laparoscopy to treat endometriosis or adhesions when appropriate (best in specialist centres).

• Interventional pain procedures (nerve blocks) in selected neuropathic pelvic pain.  

Psychological & multidisciplinary care

• Cognitive behavioural therapy (CBT), pain-management programmes, sexual therapy and psychological support.

• Best outcomes often come from multidisciplinary teams (gynaecology, pain medicine, physiotherapy, gastroenterology, urology, mental-health specialists).  

When to refer / red flags

• Sudden severe pain, fever, signs of sepsis, pregnancy-related pain, or suspected malignancy → urgent review.

• Refer to secondary care if: persistent CPP despite initial GP management, suspicion of endometriosis, fertility concerns, severe impact on daily life, or complex multisystem symptoms.  

Practical takeaways

• CPP = common, complex, and treatable — requires time, validation and a holistic plan.

• Start with history, simple tests and pelvic-floor rehab, and escalate to imaging, laparoscopy or MDT care if needed.

• Early acknowledgement and multidisciplinary management reduce long-term disability and improve quality of life.  

Remember, ALWAYS consult with your GP and/or your gynecologist for your specific treatment options. Every woman is different!

Key sources (selected): RCOG guideline on CPP (GTG 41) / NICE briefings; WHO/Latthe systematic review; StatPearls / DynaMed summaries; population prevalence reviews.